Abstract:The central portion of Meckel's cartilage degenerates almost immediately after birth. Whether autophagy is involved in this process remains unclear. Thus, to explore the role of autophagy during this process, we have detected the expression of autophagy and apoptosis-related markers in embryonic mice. In E15, Beclin1 and LC3 expressions were weak and negative in Meckel's cartilage, respectively. In E16, chondrocytes of the central portion became hypertrophic. Moderate immunoreactivities of Beclin1 and LC3 were… Show more
“…Recent studies have demonstrated that autophagy is involved in certain bone and cartilage diseases, such as cervical disc degeneration (42), cartilage degeneration of the temporomandibular joint (23), degradation of Meckel's cartilage (43) and OA (44). However, the results regarding changes in autophagy and the specific role of autophagy in the progression of OA are sometimes contradictory (25,26).…”
Accumulating evidence suggests that autophagy is closely related to the pathogenesis of osteoarthritis (OA). The aim of this study was to determine the changes in autophagy during the progression of OA and to elucidate the specific role of autophagy in OA. For this purpose, a cellular model of OA was generated by stimulating SW1353 cells with interleukin (IL)-1β and a rabbit model of OA was also established by an intra-articular injection of collagenase, followed by treatment with the autophagy specific inhibitor, 3-methyladenine (3-MA). Cell viability was analyzed by MTS assay, and the mRNA expression levels of matrix metalloproteinases (MMP)-13 and tissue inhibitor of metalloproteinase (TIMP)-1 were determined by RT-qPCR. Cartilage degeneration was examined under a light microscope, and autophagosome and chondrocyte degeneration was observed by transmission electron microscopy. The protein expression of Beclin-1 and light chain 3 (LC3)B was evaluated by western blot analysis and immunofluorescence staining. We found that the autophagy was enhanced during the early stages and was weakened during the late stages of experimental OA. The inhibition of autophagy by 3-MA significantly aggravated the degeneration of chondrocytes and cartilage in experimental OA. Our results thus determine the changes in autophagy during different stages of OA, as well as the role of impaired autophagy in the development of OA. Our data suggest that the regulation of autophagy may be a potential therapeutic strategy with which to attenuate OA.
“…Recent studies have demonstrated that autophagy is involved in certain bone and cartilage diseases, such as cervical disc degeneration (42), cartilage degeneration of the temporomandibular joint (23), degradation of Meckel's cartilage (43) and OA (44). However, the results regarding changes in autophagy and the specific role of autophagy in the progression of OA are sometimes contradictory (25,26).…”
Accumulating evidence suggests that autophagy is closely related to the pathogenesis of osteoarthritis (OA). The aim of this study was to determine the changes in autophagy during the progression of OA and to elucidate the specific role of autophagy in OA. For this purpose, a cellular model of OA was generated by stimulating SW1353 cells with interleukin (IL)-1β and a rabbit model of OA was also established by an intra-articular injection of collagenase, followed by treatment with the autophagy specific inhibitor, 3-methyladenine (3-MA). Cell viability was analyzed by MTS assay, and the mRNA expression levels of matrix metalloproteinases (MMP)-13 and tissue inhibitor of metalloproteinase (TIMP)-1 were determined by RT-qPCR. Cartilage degeneration was examined under a light microscope, and autophagosome and chondrocyte degeneration was observed by transmission electron microscopy. The protein expression of Beclin-1 and light chain 3 (LC3)B was evaluated by western blot analysis and immunofluorescence staining. We found that the autophagy was enhanced during the early stages and was weakened during the late stages of experimental OA. The inhibition of autophagy by 3-MA significantly aggravated the degeneration of chondrocytes and cartilage in experimental OA. Our results thus determine the changes in autophagy during different stages of OA, as well as the role of impaired autophagy in the development of OA. Our data suggest that the regulation of autophagy may be a potential therapeutic strategy with which to attenuate OA.
“…In surgically induced and age-related OA model, reduced autophagy and increase in apoptosis were observed [21]. Autophagy defect occured before chondrocyte cell death during Meckel cartilage degeneration [26]. Our present study also showed that knee joints from Vhl cKO mice with age-related and surgically induced OA displayed increased numbers of apoptotic chondrocytes and decreased expression of autophagy marker LC3II and Beclin1, suggesting a novel role of Vhl in maintaining cartilage homeostasis by regulating chondrocyte survival and autophagy.…”
Objective
To investigate the role of Vhl in maintaining the integrity of articular cartilage and in the development of experimental osteoarthritis (OA).
Method
Histology of articular cartilage and subchondral bone in both Vhl cKO and WT mice were analyzed by histopathology and micro-CT. Articular cartilage destruction and proteoglycan loss were scored in aged (12-month-old) mice as well as in mice with surgically induced OA. Apoptosis of cartilage in age-related and surgically induced OA was detected with TUNNEL assay. Expressions of VHL, Fas, LC-3, HIF-1Îą, HIF-2Îą, p-mTOR and MMP-13 in the knee joints were analyzed by immunostaining.
Results
No gross differences in cartilage were observed between Vhl cKO and WT mice at age 4 months. However, Vhl cKO mice displayed accelerated age-associated spontaneous OA and surgically induced OA. Cartilage destruction and proteoglycan loss were observed in the absence of Vhl. In addition, inactivation of Vhl resulted in up-regulation of HIF-2Îą and increased chondrocyte apoptosis and decreased expression of autophagy during OA development. Immunohistochemical staining also showed that Vhl deficiency led to increased expression of Fas, p-mTOR and MMP-13, and those genes were associated with cell apoptosis, autophagy and cartilage matrix breakdown, respectively.
Conclusion
Loss of Vhl in adult articular cartilage is associated with earlier dysregulation of cartilage homeostasis, characterized by an increased chondrocyte apoptosis, compromised chondrocyte autophagy, and an accelerated age-related and surgery-induced OA development. These results highlight the novel role of Vhl in maintaining joint homeostasis and OA development.
“…Despite that the chondrocytes in this portion become hypertrophic, they do not express chondrogenic differentiation markers, such as Col X and Ihh (Chung et al, 1995; this study), suggesting an arrest of chondrogenic differentiation prior to degeneration. Previous studies have implicated multiple factors and cellular processes in degeneration and resorption of Meckelâs cartilage, including several matrix metalloproteinases (Ishizeki and Nawa, 2000; Sakakura et al, 2007a, 2007b), macrophages (Harada and Ishezeki, 1998; Sakakura et al, 2005; Tsuzurahara et al, 2011), and possible autophagy and apoptosis (Trichilis and Wroblewski, 1997; Yang et al, 2012). However, the underlying mechanism that is responsible for the arrest of chondrogenic differentiation and subsequent degeneration of Meckelâs cartilage remains unknown.…”
Section: Discussionmentioning
confidence: 99%
“…However, unlike the fate of those mesoderm-derived cartilaginous elements and other CNC-derived cartilages such as cranial base, the majority of Meckelâs cartilage does not develop further and becomes degenerated. While previous studies have revealed potential contributions of several factors and cellular processes to the disappearance/resorption (Trichilis and Wroblewski, 1997; Harada and Ishizeki, 1998; Sakakura et al, 2005, 2007a, 2007b; Tsuzurahara et al, 2011; Yang et al, 2012), signaling pathways that prevent further differentiation and trigger degeneration of Meckelâs cartilage remain elusive.…”
Meckelâs cartilage is a transient supporting tissue of the embryonic mandible in mammals, and disappears by taking different ultimate cell fate along the distal-proximal axis, with the majority (middle portion) undergoing degeneration and chondroclastic resorption. While a number of factors have been implicated in the degeneration and resorption processes, signaling pathways that trigger this degradation are currently unknown. BMP signaling has been implicated in almost every step of chondrogenesis. In this study, we used Noggin mutant mice as a model for gain-of-BMP signaling function to investigate the function of BMP signaling in Meckelâs cartilage development, with a focus on the middle portion. We showed that Bmp2 and Bmp7 are expressed in early developing Meckelsâ cartilage, but their expression disappears thereafter. In contrast, Noggin is expressed constantly in Meckelâs cartilage throughout the entire gestation period. In the absence of Noggin, Meckelâs cartilage is significantly thickened attributing to dramatically elevated cell proliferation rate associated with enhanced phosphorylated Smad1/5/8 expression. Interestingly, instead of taking a degeneration fate, the middle portion of Meckelâs cartilage in Noggin mutants undergoes chondrogenic differentiation and endochondral ossification contributing to the forming mandible. Chondrocyte-specific expression of a constitutively active form of BMPRIa but not BMPRIa leads enlargement of Meckelâs cartilage, phenocopying the consequence of Noggin deficiency. Our results demonstrate that elevated BMP signaling prevents degeneration and leads to endochondral ossification of Meckelâs cartilage, and support the idea that withdrawal of BMP signaling is required for normal Meckelâs cartilage development and ultimate cell fate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.